Mesh Bio: The role of deep tech in modern healthcare
What if we can prevent catastrophic diseases such as diabetes, kidney failure, and stroke with deep tech? The word deep tech might still be unfamiliar to people’s ears as it first emerged in 2014.
Mesh Bio, a health deep tech startup, secured investment from East Ventures
Mesh Bio, a Singapore-based health deep tech startup in transforming chronic disease management through predictive analytics, announced that it had raised an undisclosed amount of funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. The funding will be allocated to further develop the digital twin technologies in chronic disease management and to expand its services across Southeast Asia, mainly Indonesia, Malaysia, and the Philippines.